**Core Concept**
Steroids play a crucial role in the management of bronchopulmonary dysplasia (BPD), a chronic respiratory disease affecting premature infants. The use of corticosteroids in BPD aims to reduce inflammation in the lungs, thereby improving lung function and oxygenation.

**Why the Correct Answer is Right**
In BPD, the premature lung is unable to produce sufficient surfactant, leading to recurring episodes of respiratory distress. Corticosteroids, such as dexamethasone or beclomethasone, are used to decrease inflammation in the airspaces, increase surfactant production, and improve lung compliance. This results in improved oxygenation and reduced need for mechanical ventilation. The use of steroids in BPD is a well-established practice in neonatology, with the goal of reducing the severity and duration of the disease.

**Why Each Wrong Option is Incorrect**
**Option B:** Pulmonary hypoplasia is a condition where the lungs fail to develop properly, often due to congenital anomalies or oligohydramnios. While steroids may be used in some cases of pulmonary hypoplasia, it is not a primary indication for their use in neonates.
**Option C:** Oesophageal atresia is a congenital anomaly of the esophagus, which may require surgical intervention. Steroids are not a primary treatment for oesophageal atresia.
**Option D:** While steroids have various indications in neonatology, BPD is a specific condition where their use is well established.

**Clinical Pearl / High-Yield Fact**
A key aspect of managing BPD is monitoring for potential side effects of steroid therapy, such as growth restriction, hypertension, and gastrointestinal disturbances. Regular assessment of lung function and oxygenation is crucial to adjust steroid treatment and minimize complications.

**✓ Correct Answer: A. Brochopulmonary dysplasia**